Get the Stockscreener App
1.855
2.52%
0.045
Mindwalk Holdings Corp stock is traded at $1.855, with a volume of 108.18K.
It is up +2.52% in the last 24 hours and down -16.04% over the past month.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
See More
Previous Close:
$1.81
Open:
$1.87
24h Volume:
108.18K
Relative Volume:
0.21
Market Cap:
$83.54M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.40%
1M Performance:
-16.04%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.85
$1.9076
1-Week Range:
$1.80
$2.19
52-Week Range:
$1.42
$2.30
Mindwalk Holdings Corp Stock (HYFT) Company Profile
Compare HYFT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HYFT
Mindwalk Holdings Corp
|
1.86 | 83.54M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.42 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.45 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.17 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.67 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.40 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mindwalk Holdings Corp Stock (HYFT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-22 | Initiated | H.C. Wainwright | Buy |
| Oct-25-21 | Initiated | The Benchmark Company | Buy |
Mindwalk Holdings Corp Stock (HYFT) Latest News
MindWalk (HYFT) Announces Share Repurchase Plan - GuruFocus
MindWalk Holdings (HYFT) Announces 2.3M Share Buyback Program - GuruFocus
MindWalk Holdings Corp. authorizes a Buyback Plan. - MarketScreener
MindWalk Holdings Corp. announces an Equity Buyback for 2,300,000 shares. - MarketScreener
MindWalk Holdings announces 2.3M share buyback program - MSN
MindWalk announces $2.3 million share repurchase program By Investing.com - Investing.com Nigeria
MindWalk Holdings Initiates Share Repurchase Program to Enhance Shareholder Value - TipRanks
MindWalk announces $2.3 million share repurchase program - Investing.com India
MindWalk Announces Share Repurchase Program - The Joplin Globe
MindWalk Unveils Dual-Pathway Regimen in Longevity Therapeutics - MSN
MindWalk Holdings Corp. (HYFT) Surges with 45% Revenue Growth and Strategic AI-Focused Rebrand - Insider Monkey
MindWalk expands GLP-1 program with AI-discovered longevity pathway By Investing.com - Investing.com Nigeria
MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity - The AI Journal
Accelerating Drug Discovery through First End-to-End Bio-Native AI Platform (09/22/2025 00:00 - MarketScreener
MindWalk stock soars on dual-pathway GLP-1 therapeutic advancement By Investing.com - Investing.com South Africa
MindWalk stock soars on dual-pathway GLP-1 therapeutic advancement - Investing.com
MindWalk (HYFT) Unveils Breakthrough in GLP-1 Therapeutic Progra - GuruFocus
MindWalk expands GLP-1 program with AI-discovered longevity pathway - Investing.com
MindWalk advances AI-designed GLP-1 program with first-in-class dual-pathway regimen for aging and longevity - MarketScreener
MindWalk : Accelerating Drug Discovery through First End-to-End Bio-Native AI Platform - MarketScreener
How MindWalk Holdings' Rebranding and Improved Earnings May Impact HYFT Investors - Yahoo Finance
MindWalk Holdings Reports Strong Revenue Growth and Improved Margins - TipRanks
MindWalk Holdings Corp (HYFT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
MindWalk Holdings Corp (HYFT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Rebranding - GuruFocus
MindWalk Holdings Reports Q3 2025 Financial Results and Strategic Growth - TipRanks
MindWalk Holdings Corp reports results for the quarter ended July 31Earnings Summary - TradingView
MindWalk Holdings Corp. Reports Earnings Results for the First Quarter Ended July 31, 2025 - MarketScreener
MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly - PharmiWeb.com
Earnings call transcript: MindWalk Inc. reports strong Q1 2025 performance, rebrands from ImmunoPrecise Antibodies - Investing.com UK
MindWalk Holdings Corp. (HYFT) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet - Business Wire
MindWalk Holdings Reports Record Revenue and Strategic Divestiture - TipRanks
MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet | FinancialContent - FinancialContent
MindWalk : 2025 Combined Financial Statements - MarketScreener
MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025 - Business Wire
MindWalk Holdings Corp.HYFTStock Price Today - Zacks Investment Research
HYFT Stock Price and Chart — NASDAQ:HYFT - TradingView
ImmunoPrecise Antibodies rebrands as MindWalk, changes ticker to HYFT By Investing.com - Investing.com Canada
HYFT's Rebranding: A Strategic Pivot in Biotech's AI-Driven Future - AInvest
ImmunoPrecise Antibodies rebrands as MindWalk, changes ticker to HYFT - Investing.com
Immunoprecise rebrands as Mindwalk, announces Nasdaq ticker change to "HYFT" - MarketScreener
ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT” - FinancialContent
Leading Biotech ImmunoPrecise Antibodies Joins Major H.C. Wainwright Investment Conference in New York - Stock Titan
AI-Powered Universal Dengue Vaccine Breakthrough: ImmunoPrecise's LENSai Platform Advances to Animal Studies - Stock Titan
Strategic Acquisition: AVS Bio Expands Global Biologics Reach with ImmunoPrecise Europe Buyout - Stock Titan
ImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDA - Business Wire
Mindwalk Holdings Corp Stock (HYFT) Financials Data
There is no financial data for Mindwalk Holdings Corp (HYFT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.20%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):